Idiopathic multicentric Castleman disease developing after a diagnosis of sarcoidosis: A case report and literature review

被引：0

作者：

Muramatsu, Takumi ^{[1
]}

Kono, Masato ^{[1
]}

Ishige, Masaki ^{[1
]}

Saito, Takahiko ^{[1
]}

Higasa, Misato ^{[1
]}

Nihashi, Fumiya ^{[1
]}

Aono, Yuya ^{[1
]}

Katsumata, Mineo ^{[1
]}

Miwa, Hideki ^{[1
]}

Miki, Yoshihiro ^{[1
]}

Misaki, Taro ^{[3
]}

Otsuki, Yoshiro ^{[4
]}

Hashimoto, Dai ^{[1
]}

Enomoto, Noriyuki ^{[2
]}

Suda, Takafumi ^{[2
]}

Nakamura, Hidenori ^{[1
,5
]}

机构：

[1] Seirei Hamamatsu Gen Hosp, Dept Resp Med, Hamamatsu 4308558, Japan

[2] Hamamatsu Univ Sch Med, Dept Internal Med, Div 2, Hamamatsu 4313192, Japan

[3] Seirei Hamamatsu Gen Hosp, Dept Nephrol, Hamamatsu 4308558, Japan

[4] Seirei Hamamatsu Gen Hosp, Dept Pathol, Hamamatsu 4308558, Japan

[5] Nishiyama Hosp, Div Internal Med, Hamamatsu 4328001, Japan

来源：

RESPIRATORY MEDICINE CASE REPORTS | 2025年 / 54卷

关键词：

Idiopathic multicentric Castleman disease; Sarcoidosis; Tocilizumab; LYMPHOMA;

D O I：

10.1016/j.rmcr.2025.102188

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

A 72-year-old woman presented with an abnormal shadow on chest radiograph. She was histologically diagnosed with sarcoidosis 20 years previously, and prednisolone was initiated 8 years previously. Computed tomography revealed centrilobular micronodules and bronchovascular bundle thickening in both lungs with multicentric lymphadenopathies; multiple pulmonary nodular lesions appeared during prednisolone tapering. Laboratory findings included polyclonal hypergammaglobulinemia and elevated interleukin-6 levels. Surgical lung biopsy revealed marked lymphoplasmacytic infiltration with lymphoid aggregates. The patient tested negative for human herpesvirus-8 and clinically diagnosed with idiopathic multicentric Castleman disease. The coexistence of sarcoidosis and Castleman disease is rare; this case improved with additional tocilizumab treatment.

引用

页数：7

共 21 条

[1] Castleman B., Iverson L., Menendez V.P., Localized mediastinal lymphnode hyperplasia resembling thymoma, Cancer, 9, pp. 822-830, (1956)
[2] Dispenzieri A., Fajgenbaum D.C., Overview of castleman disease, Blood, 135, pp. 1353-1364, (2020)
[3] Liu A.Y., Nabel C.S., Finkelman B.S., Et al., Idiopathic multicentric Castleman's disease: a systematic literature review, Lancet. Haematol., 3, pp. e163-e175, (2016)
[4] Fajgenbaum D.C., Uldrick T.S., Bagg A., Srkalovic, Et al., International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease, Blood, 129, pp. 1646-1657, (2017)
[5] Iannuzzi M.C., Rybicki B.A., Sarcoidosis A.S.T., N. Engl. J. Med., 357, pp. 2153-2165, (2007)
[6] Brincker H., The sarcoidosis-lymphoma syndrome, Br. J. Cancer, 54, pp. 467-473, (1986)
[7] Bonifazi M., Bravi F., Gasparini S., Et al., Sarcoidosis and cancer risk: systematic review and meta-analysis of observational studies, Chest, 147, pp. 778-791, (2015)
[8] Rice B.L., Farver C.F., Pohlman B., Burkey B.B., Parambil J.G., Concomitant Castleman's disease and sarcoidosis, Am. J. Med. Sci., 341, pp. 257-259, (2011)
[9] Awano N., Inomata M., Kondoh K K., Et al., Mixed-type multicentric Castleman's disease developing during a 17-year follow-up of sarcoidosis, Intern. Med., 51, pp. 3061-3066, (2012)
[10] Mohammed A., Janku F., Qi M., Kurzrock R., Castleman's disease and sarcoidosis, a rare association resulting in a “mixed” response: a case report, J. Med. Case Rep., 9, (2015)

← 1 2 3 →